Grote–Hynes rate theory

XL Xinyang Li
AM Arkajit Mandal
PH Pengfei Huo
request Request a Protocol
ask Ask a question
Favorite

In multidimensional transition state theory, the reactant to product rate constant is given as40,4446

where {Ωi0} are normal-mode frequencies of the Hamiltonian in the reactant well, and {Ω2,...,ΩN} are the stable normal-mode frequencies at the barrier, such that Ωi2>0 for i > 1, and Ω12<0 is the imaginary frequency of the transition state.

Considering a simplified (classical) model of the molecule-cavity hybrid system, HHvib=P22M+E(R)+pc22+12ωc2(qc+2ωc3χμ(R))2 which only contains two DOFs {qc, R} (and are viewed as classical DOFs), the normal-mode frequencies at R0 are Ω±2=12(ω02+C02ωc2+ωc2)±12(ω02+C02ωc2+ωc2)24ωc2ω02, where C0=2ωcMχμ0. The normal-mode frequencies at R are Ω±2=12(ωb2+C2ωc2+ωc2)±12(ωb2+C2ωc2+ωc2)2+4ωc2ωb2, where C=2ωcMχμ. Details of the derivation of these normal-mode frequencies are provided in Supplementary Note 2. Using these normal-mode frequencies, the rate constant in Eq. (10) for the H^H^vib model is expressed as k=12πΩ+ΩΩ+eβEb, where Eb is the energy barrier. Using the fact that (Ω+Ω)2=ωb2ωc2 and (Ω+Ω)2=ω02ωc2 (see the general proof in ref. 42), the rate constant can be further expressed as follows

where kTST=ω02πeβEb, κGH=λωb is the transmission coefficient in the GH theory, λ=(Ω)2, which is Eq. (6). Same procedure can also be used to derive the expressions46 of the κGH for the model Hamiltonian in Eq. (1). Alternatively, one can derive the transmission coefficient κGH from the equation of motion39,56, with the details provided in Supplementary Note 4.

When considering the phonon bath H^vib under the Markovian limit (while consider qc as the non-Markovian coordinate), λ can be obtained by solving the following equation

where κGH=λωb. We consider a bath friction coefficient ζ = 400 cm−1 according to the spectral density J(ω). The detailed derivations of Eq. (12), as well as the assessment of the validity of the Markovian limit of the phonon bath are provided in Supplementary Note 4.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A